128. Kongress der Deutschen Gesellschaft für Innere Medizin
zur Liste
Ann-Sophie Warmeling
Janssen-Cilag GmbH Germany
  • Vortrag Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study Speaker
    Datum: 02.05.2022 , Zeit: 11:07 | Thema: Infektiologie
    Details